As one of the world’s leading life sciences companies, we play an important role in global health and take our responsibilities very seriously. Our mission is simple: improve health, improve lives.


Our diverse, global team of more than 75,000 employees across 100 countries is core to our ability to innovate and meet our customer needs.


As we commit to improving health and lives across our global communities, we also seek to take actions that will improve the environment and evolve operations in increasingly sustainable ways.


Together with our employees and The Labcorp Charitable Foundation, we work collaboratively on initiatives that positively impact communities across the globe and align with the focus areas of health and welfare, education and community.

A Message from Labcorp’s Chairman and CEO

When the world faces challenges, extraordinary companies step up to help society overcome obstacles and adversity.

Over the past two years, the world sought solutions to numerous needs related to the ongoing pandemic. These needs included access to COVID-19 PCR testing as well as the ability to detect and track new COVID-19 variants and increase the use of lifesaving COVID-19 treatment options such as antiviral therapies.

Our more than 75,000 employees’ greatest achievements in 2021 involved providing answers to these and many other health challenges in support of our customers, patients and communities. This ability to provide answers is at the heart of this year’s corporate responsibility report.

Last year, I said we were deeply focused on every aspect of fighting COVID-19, and I’m proud of Labcorp’s continued contributions to help the world combat the pandemic. This was exemplified by our receiving U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for multiple innovations, our drug development work in support of new vaccines and therapies, aiding the U.S. Centers for Disease Control and Prevention (CDC) in identifying and monitoring variants, and providing increased access to COVID-19 PCR testing. And we accomplished all that while making notable progress on our other priorities, including in areas of great need such as oncology, women’s health and autoimmune diseases.

These achievements are considerable in their own right, but what is truly special about Labcorp is that we did not stop there. We deepened the impact of our environment, social and governance (ESG) strategy and our compliance and ethics through our corporate governance practices; we’ve strengthened our efforts to increase diversity and inclusion among our leadership and across our global organization; and we began pursuing a science-based target. We welcome the opportunity for continuous improvement towards achieving our and society’s goals in 2022 and beyond.

The true power of Labcorp lies in the intersections of our diverse, global expertise. It is through these connections that we help create breakthrough and transformative approaches to the world’s most prominent healthcare challenges and ultimately drive health care forward. Our employees improve health and improve lives through actions grounded in science, technology and innovation along with a commitment to act with integrity.

The pandemic’s challenges have heartened our confidence that no matter what tomorrow brings, we are ready to pursue answers.

Adam Signature

Adam Schechter
Chairman and Chief Executive Officer

Adam Schechter